AMG 745: Clinical Trials

1 trial of AMG 745, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1

Follow AMG 745: new trials by email Literature Review of AMG 745 trials Research Report on AMG 745

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AMG 745 in Subjects With Age-associated Muscle Loss
AMG 745 0.3 mg/kg, AMG 745 1.0 mg/kg, AMG 745 3.0 mg/kg - Age-associated Muscle Loss
Phase 2WithdrawnAmgen2010-04-012018-10-04

Conditions studied

Atrophy (1)  ·  Frailty (1)  ·  Motor Activity (1)  ·  Muscular Atrophy (1)  ·  Sedentary Behavior (1)

Sponsors

Amgen (1)